Independent Director · AN2 Therapeutics, Inc. (ANTX)

Chair, Nominating/Governance Committee

Rob Readnour, Ph.D director compensation at AN2 Therapeutics: $68.4K

Fiscal year 2025 director compensation for Rob Readnour, Ph.D at AN2 Therapeutics, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 22, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Rob Readnour, Ph.D’s full pay file as a PDF — free

More than this page: up to 10 years of Rob’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Rob Readnour, Ph.D and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

AN2 Therapeutics Director Compensation Table · all 3 fiscal years held
In US dollars, as AN2 Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$48,000$0$20,393—$68,393
FY2024$44,859$778$104,514—$150,151
FY2023$43,000—$103,138—$146,138

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: AN2 Therapeutics, Inc. DEF 14A filed April 22, 2026, accession 0001193125-26-170314, and prior-year filings. Open the filing on EDGAR.

How this page was built: the AN2 Therapeutics, Inc. filed document, accession 0001193125-26-170314. Every figure is read from that document and cited to the page and table it appears in. Filed April 22, 2026.

Get the AN2 Therapeutics Board Governance Report

$68,393 Rob Readnour, Ph.D, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 22, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

AN2 Therapeutics pays directors a $40,000 cash retainer and $104,546 in Options.

Committees

FY2025 · as the proxy prints them

Nominating/Governance (Chair)

The rest of the AN2 Therapeutics board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Eric EasomChair of the Board—
Gilbert Lynn Marks, M.DIndependent Director$57,904
Joseph ZakrzewskiIndependent Director$71,893
Kabeer AzizIndependent Director$57,904
Margaret FitzPatrickLead Independent Director$89,393
Melvin Spigelman, M.DIndependent Director$67,893
Patricia MartinIndependent Director$72,240
Stephanie WongIndependent Director$79,393

The full AN2 Therapeutics compensation record

free company brief

This page is one director within AN2 Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Order ANTX

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report